These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 9316528)

  • 1. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
    Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
    J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
    Dunselman PH;
    Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Guazzi M; Melzi G; Agostoni P
    Am J Cardiol; 1997 Dec; 80(12):1572-6. PubMed ID: 9416938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
    Ethn Dis; 2003; 13(1):71-9. PubMed ID: 12723015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
    Davie AP; Dargie HJ; McMurray JJ
    Circulation; 1999 Jul; 100(3):268-73. PubMed ID: 10411851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA; Berezin AE
    Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term combined therapy with losartan and an angiotensin-converting enzyme inhibitor improves functional capacity in patients with left ventricular dysfunction.
    Dayi SU; Akbulut T; Akgoz H; Terzi S; Sayar N; Aydin A; Bilsel T; Ciloglu F
    Acta Cardiol; 2005 Aug; 60(4):373-7. PubMed ID: 16128369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.
    Hamroff G; Katz SD; Mancini D; Blaufarb I; Bijou R; Patel R; Jondeau G; Olivari MT; Thomas S; Le Jemtel TH
    Circulation; 1999 Mar; 99(8):990-2. PubMed ID: 10051289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS).
    Pitt B; Chang P; Grossman W; Dunlay M; Timmermans PB
    Am J Cardiol; 1996 Nov; 78(10):1129-31. PubMed ID: 8914876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
    Blanchet M; Sheppard R; Racine N; Ducharme A; Curnier D; Tardif JC; Sirois P; Lamoureux MC; De Champlain J; White M
    Am Heart J; 2005 May; 149(5):938.e1-7. PubMed ID: 15894946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of enalapril+losartan treatment with cardiopulmonary exercise test in patients with left ventricular dysfunction.
    Akbulut T; Akgöz H; Dayi SU; Celik SE; Gürkan U; Tayyareci G
    Angiology; 2006; 57(2):181-6. PubMed ID: 16518525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.
    Vescovo G; Dalla Libera L; Serafini F; Leprotti C; Facchin L; Volterrani M; Ceconi C; Ambrosio GB
    Circulation; 1998 Oct; 98(17):1742-9. PubMed ID: 9788828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure.
    Guazzi M; Palermo P; Pontone G; Susini F; Agostoni P
    Am J Cardiol; 1999 Nov; 84(9):1038-43. PubMed ID: 10569660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
    Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
    Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects of endothelial dysfunction reversion in patients with congestive heart failure].
    Vizir VA; Berezin AE
    Klin Med (Mosk); 2000; 78(7):36-9. PubMed ID: 10979640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.